Class information for:
Level 1: MUCOPOLYSACCHARIDOSES//HUNTER SYNDROME//MAROTEAUX LAMY SYNDROME

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
1157 2717 31.6 69%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
330 17366 FABRY DISEASE//GAUCHER DISEASE//MUCOPOLYSACCHARIDOSES

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MUCOPOLYSACCHARIDOSES Author keyword 669 80% 15% 421
2 HUNTER SYNDROME Author keyword 222 86% 4% 114
3 MAROTEAUX LAMY SYNDROME Author keyword 221 98% 2% 55
4 MUCOPOLYSACCHARIDOSIS TYPE II Author keyword 181 94% 2% 64
5 ALPHA L IDURONIDASE Author keyword 171 95% 2% 57
6 HURLER SYNDROME Author keyword 170 89% 3% 78
7 LYSOSOMAL DIS UNIT Address 125 65% 4% 119
8 SANFILIPPO SYNDROME Author keyword 118 90% 2% 52
9 MUCOPOLYSACCHARIDOSIS VI Author keyword 114 95% 1% 38
10 MUCOPOLYSACCHARIDOSIS TYPE I Author keyword 111 87% 2% 54

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 MUCOPOLYSACCHARIDOSES 669 80% 15% 421 Search MUCOPOLYSACCHARIDOSES Search MUCOPOLYSACCHARIDOSES
2 HUNTER SYNDROME 222 86% 4% 114 Search HUNTER+SYNDROME Search HUNTER+SYNDROME
3 MAROTEAUX LAMY SYNDROME 221 98% 2% 55 Search MAROTEAUX+LAMY+SYNDROME Search MAROTEAUX+LAMY+SYNDROME
4 MUCOPOLYSACCHARIDOSIS TYPE II 181 94% 2% 64 Search MUCOPOLYSACCHARIDOSIS+TYPE+II Search MUCOPOLYSACCHARIDOSIS+TYPE+II
5 ALPHA L IDURONIDASE 171 95% 2% 57 Search ALPHA+L+IDURONIDASE Search ALPHA+L+IDURONIDASE
6 HURLER SYNDROME 170 89% 3% 78 Search HURLER+SYNDROME Search HURLER+SYNDROME
7 SANFILIPPO SYNDROME 118 90% 2% 52 Search SANFILIPPO+SYNDROME Search SANFILIPPO+SYNDROME
8 MUCOPOLYSACCHARIDOSIS VI 114 95% 1% 38 Search MUCOPOLYSACCHARIDOSIS+VI Search MUCOPOLYSACCHARIDOSIS+VI
9 MUCOPOLYSACCHARIDOSIS TYPE I 111 87% 2% 54 Search MUCOPOLYSACCHARIDOSIS+TYPE+I Search MUCOPOLYSACCHARIDOSIS+TYPE+I
10 HURLER 107 97% 1% 31 Search HURLER Search HURLER

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MAROTEAUX LAMY SYNDROME 433 91% 7% 183
2 HURLER SYNDROME 304 80% 7% 190
3 N ACETYLGALACTOSAMINE 4 SULFATASE 267 92% 4% 108
4 SANFILIPPO SYNDROME 238 94% 3% 87
5 ALPHA L IDURONIDASE 173 72% 5% 134
6 BETA GLUCURONIDASE DEFICIENCY 155 71% 5% 127
7 ENZYME REPLACEMENT THERAPY 154 25% 19% 526
8 HUNTER SYNDROME 150 75% 4% 109
9 MUCOPOLYSACCHARIDOSIS TYPE II 127 80% 3% 78
10 MPS I 116 97% 1% 33

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Early initiation of enzyme replacement therapy for the mucopolysaccharidoses 2014 13 76 83%
Diagnostic evaluation, monitoring, and perioperative management of spinal cord compression in patients with Morquio syndrome 2015 2 26 81%
Newborn Screening for Lysosomal Storage Diseases 2015 2 63 63%
Mucopolysaccharidosis VI 2010 71 88 92%
Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA 2013 20 70 90%
Mucopolysaccharidosis Type IVA (Morquio A Disease): Clinical Review and Current Treatment: A Special Review 2011 47 54 85%
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy 2008 94 34 91%
Overview of the mucopolysaccharidoses 2011 31 58 95%
Current and potential therapeutic strategies for mucopolysaccharidoses 2014 5 104 89%
Lysosomal storage disease: Gene therapy on both sides of the blood-brain 2015 2 132 44%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 LYSOSOMAL DIS UNIT 125 65% 4.4% 119
2 AMSTERDAM LYSOSOME SPHINX 30 79% 0.7% 19
3 WILLINK BIOCHEM GENET UNIT 25 34% 2.2% 59
4 MED GENET SERV 13 16% 2.6% 71
5 ANTHROPOMETRY 11 100% 0.2% 6
6 ERRO INNATOS METAB 11 69% 0.3% 9
7 METAB DIS H7 270 8 100% 0.2% 5
8 STUDY INBORN ERRORS METAB 6 48% 0.4% 10
9 DIAG THER Y LYSOSOMAL DISORDERS 6 80% 0.1% 4
10 MPS STEM CELL GRP 6 80% 0.1% 4

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000122656 METACHROMATIC LEUKODYSTROPHY//ARYLSULFATASE A//MULTIPLE SULFATASE DEFICIENCY
2 0.0000083353 POMPE DISEASE//GLYCOGEN STORAGE DISEASE TYPE II//ACID ALPHA GLUCOSIDASE
3 0.0000078598 GLOBOID CELL LEUKODYSTROPHY//KRABBE DISEASE//PSYCHOSINE
4 0.0000063389 FABRY DISEASE//ALPHA GALACTOSIDASE A//FABRYS DISEASE
5 0.0000060351 GM2 GANGLIOSIDOSIS//SANDHOFF DISEASE//TAY SACHS DISEASE
6 0.0000059536 GAUCHER DISEASE//GLUCOCEREBROSIDASE//GAUCHERS DISEASE
7 0.0000057603 ASPARTYLGLUCOSAMINURIA//GLYCOSYLASPARAGINASE//ASPARTYLGLUCOSAMINIDASE
8 0.0000057572 FUCOSIDOSIS//ALPHA L FUCOSIDASE//FUCOSE DEHYDROGENASE
9 0.0000057280 MYHRE SYNDROME//MICROSPHEROPHAKIA//GELEOPHYSIC DYSPLASIA
10 0.0000054845 I CELL DISEASE//MANNOSE 6 PHOSPHATE//MUCOLIPIDOSIS TYPE III